case_images: PMC8276647_01
case_images: Two days after sclerotherapy, with telangiectatic matting .
case_images: jvb-19-e20190159-g01-en.jpg
case_images: PMC8276647_01_jvb-19-e20190159-g01-en.jpg
case_images: gf0100
case_images: She developed a large expanse of telangiectatic matting (approximately 10 x 15 cm) in the area surrounding the vessels that had been treated, about 2 days after the procedure (Figure 1).
case_images: Unsatisfactory results after attempt to treat with intense pulsed light.
case_images: jvb-19-e20190159-g02-en.jpg
case_images: PMC8276647_01_jvb-19-e20190159-g02-en.jpg
case_images: gf0200
case_images: In the opinions of the same evaluator and of the patient, there was no more than mild attenuation of the condition (Figure 2).
case_images: Appearance after 1 week using brimonidine tartrate.
case_images: jvb-19-e20190159-g03-en.jpg
case_images: PMC8276647_01_jvb-19-e20190159-g03-en.jpg
case_images: gf0300
case_images: After 7 days of regular use of this medication, considerable improvement was observed (Figure 3).
case_images: Result after 2 weeks using brimonidine tartrate.
case_images: jvb-19-e20190159-g04-en.jpg
case_images: PMC8276647_01_jvb-19-e20190159-g04-en.jpg
case_images: gf0400
case_images: A joint decision was taken to continue applying the medication for a further 7 days, with very satisfactory results (Figure 4).
case_images: Follow-up, 6 months after appearance of telangiectatic matting.
case_images: jvb-19-e20190159-g05-en.jpg
case_images: PMC8276647_01_jvb-19-e20190159-g05-en.jpg
case_images: gf0500
case_images: The patient has been in clinical follow-up for 6 months (Figure 5) and no rebound effect has been observed to date.